Uniphos Enterprises Ltd
NSE: UNIENTER BSE: 500429
Incorporated in 1969, Uniphos Enterprises Ltd is in the business of trading of chemicals and other products[1]
₹102
52W: ₹87.4 — ₹173
PE 35.9 · Book ₹409 · -75% vs bookMarket Cap₹712 Cr
Stock P/E35.9Price to Earnings
ROCE0.06%Return on Capital
ROE0.01%Return on Equity
Div. Yield0.5%Face Value ₹2
Strengths
- +Company is almost debt free.
- +Stock is trading at 0.26 times its book value
- +Market value of investments Rs.2,615 Cr. is more than the Market Cap Rs.723 Cr.
- +Company has been maintaining a healthy dividend payout of 487%
Weaknesses
- −Company has a low return on equity of 0.94% over last 3 years.
- −Earnings include an other income of Rs.25.0 Cr.
Shareholding Pattern
Promoters73.79%
FIIs15.82%
DIIs0%
Public10.39%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 73.79% | 73.79% | 73.79% | 73.79% | 73.79% | 73.79% | 73.79% | 73.79% |
| FIIs | 15.71% | 15.72%▲0.0 | 15.72% | 15.72% | 15.71%▼0.0 | 15.71% | 15.71% | 15.82%▲0.1 |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 10.49% | 10.48%▼0.0 | 10.49%▲0.0 | 10.49% | 10.5%▲0.0 | 10.5% | 10.5% | 10.39%▼0.1 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 50.65 | 3.03 | 30.48 | 5.1 | 72.9 | 5.86 | 0 | 0 |
| Expenses | 0.75 | 0.69 | 51.51 | 3.78 | 30.96 | 6.1 | 74.5 | 6.7 | 1.1 | 0.97 |
| Operating Profit | -0.75 | -0.69 | -0.86 | -0.75 | -0.48 | -1 | -1.6 | -0.84 | -1.1 | -0.97 |
| OPM % | 0% | 0% | -1.7% | -24.75% | -1.57% | -19.61% | -2.19% | -14.33% | 0% | 0% |
| Net Profit | 39.36 | -0.03 | -0.63 | -0.15 | 3.86 | -1.86 | -1.58 | -0.74 | 23.16 | -1.01 |
| EPS ₹ | 5.66 | 0 | -0.09 | -0.02 | 0.56 | -0.27 | -0.23 | -0.11 | 3.33 | -0.15 |
AI Insights
Revenue Trend
TTM revenue at ₹79Cr, down 29.5% YoY. OPM at -6%.
Debt Position
Borrowings at ₹1Cr. Debt-to-equity ratio: 0.00x. Healthy balance sheet.
Institutional Flow
DIIs: 0% (+0.00pp change). FIIs: 15.82% (+0.13pp change). Promoters hold 73.79%.
Margin & Efficiency
ROCE declining from 2% (Mar 2014) to 0% (Mar 2025). Working capital days: -6.
Valuation
PE 35.9x with 0.06% ROCE. Price is -75% above book value of ₹409. Dividend yield: 0.5%.
Recent Announcements
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 15 Apr - Regulation 74(5) compliance certificate for quarter ended March 31, 2026.
- Closure of Trading Window 31 Mar - Uniphos Enterprises: trading window closed from 1 April 2026 until 48 hours after audited results uploaded.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 7 Feb - Please find attached copy of newspaper publication of an extract of Unaudited Financial Results for the quarter and nine months ended 31st December, 2025.
- Board Meeting Outcome for UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 31ST DECEMBER, 2025 6 Feb - Unaudited Q3/nine-month results to 31 Dec 2025: YTD profit Rs2,141.38 lakh; OCI +Rs50,909.28 lakh.
- UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 31ST DECEMBER, 2025 6 Feb
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse